Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Docetaxel 33 Radiosurgery 23 Radiotherapy 21 Sunitinib 20 pembrolizumab 18 Gemcitabine 16 Cisplatin 16 Androgen Antagonists 15 Nivolumab 14 enzalutamide 13 Goserelin 13 Prednisone 12 Leuprolide 12 Blood Specimen Collection 12 Abiraterone Acetate 12 bicalutamide 11 aldesleukin 11 Surveys and Questionnaires 11 Cyclophosphamide 11 Gonadotropin-Releasing Hormone 10 Bevacizumab 10 Multiparametric Magnetic Resonance Imaging 9 Carboplatin 9 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8 Triptorelin Pamoate 8 Radiotherapy, Intensity-Modulated 8 Filgrastim 8 Epirubicin 8 Chemotherapy, Adjuvant 8 Brachytherapy 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Blood Donation × Genitourinary × Clear all

NCT04060589 2023-03-22

ReIMAGINE Prostate Cancer Risk

University College, London

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡